> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# LabCorp EUA Covers Asymptomatic, Pooled Covid Samples
- URL: https://www.fdaweb.com/labcorp-eua-covers-asymptomatic-pooled-covid-samples/
- Published: 2020-07-27T12:00:00.000Z
- Updated: 2026-09-14T16:22:40.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147288

FDA has reissued an emergency use authorization to LabCorp for its Covid-19 RT-PCR Test to include two new indications for use — testing for people who do not have Covid-19 symptoms or who have no reason to suspect Covid-19 infection, and to allow pooled sample testing. The reissuance is based on data showing the test’s ability to detect SARS-CoV-2 in a general, asymptomatic population. Additionally, it covers pooled samples containing up to five individual swab specimens collected under observation. “Sample pooling allows for fewer tests to be run overall, conserving resources and potentially allowing more samples to be evaluated quicker,” an [FDA release](https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or?ref=fdaweb.com) says.  

FDA says it recognizes that organizations may want to conduct screening of asymptomatic people as part of a broader strategy to help ensure the safety of their employees, patients, students and others. The test remains prescription-only and is authorized for human specimen collection either at home using the Pixel by LabCorp or other home sample collection kits authorized for use with LabCorp’s test, or by a health care provider, it says.